financetom
Business
financetom
/
Business
/
TransDigm Group Insider Sold Shares Worth $27,909,629, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TransDigm Group Insider Sold Shares Worth $27,909,629, According to a Recent SEC Filing
Jun 13, 2024 12:42 AM

03:17 AM EDT, 06/13/2024 (MT Newswires) -- Robert J Small, Director, on June 12, 2024, sold 21,210 shares in TransDigm Group ( TDG ) for $27,909,629. Following the Form 4 filing with the SEC, Small has control over a total of 681,542 shares of the company, with 15,920 shares held directly and 665,622 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1260221/000091957424003630/xslF345X03/ownership.xml

Price: 1,322.70, Change: +0.57, Percent Change: +0.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canadian oil tycoon proposes aiding US in Venezuela's oil revival
Canadian oil tycoon proposes aiding US in Venezuela's oil revival
Mar 11, 2026
* Adam Waterous says Canada's heavy oil expertise could be useful in Venezuela * Strathcona willing to send technical team * Venezuelan oil revival could affect Canadian crude exports in the long term By Amanda Stephenson CALGARY, Jan 13 (Reuters) - A Canadian tycoon who heads one of North America's fastest-growing oil companies is advocating for his country to lend...
BMO on Groupe Dynamite's Updated Guidance
BMO on Groupe Dynamite's Updated Guidance
Mar 11, 2026
01:23 PM EST, 01/13/2026 (MT Newswires) -- Groupe Dynamite ( GRGDF ) announced preliminary quarter-to-date FQ4/25E sales growth and updated its F2025E guidance, notes BMO. According to analyst Stephen MacLeod, who has an outperform rating on the company's shares and raised his target price to $98.00, We believe strong comps momentum should continue to be positive for the stock, combined...
US FDA extends review of Travere's drug for rare kidney disease
US FDA extends review of Travere's drug for rare kidney disease
Mar 11, 2026
Jan 13 (Reuters) - The U.S. Food and Drug Administration ‌has extended ​its review for the ‍expanded use ⁠of ⁠Travere Therapeutics' drug ‌to treat ​a type of ⁠rare ‍kidney ​disorder, the drugmaker said on Tuesday. The agency ‍will now give its decision on ​April ‍13, compared to its previous ​action date of January 13. ...
Weinstein's Saba Capital pushes for Workspace wind-down amid trading struggles
Weinstein's Saba Capital pushes for Workspace wind-down amid trading struggles
Mar 11, 2026
Jan 13 (Reuters) - Boaz Weinstein's Saba Capital, which holds about a 13.5% stake in London-focused flexible office-space provider Workspace, sent a ‌letter on Tuesday urging the company to pursue ​a managed wind-down. Considering the company's (Workspace) persistent ‍trading discount, refinancing challenges, and ⁠structural ⁠impediments in its shareholder base, the current model ‌no longer represents the ​best path to value...
Copyright 2023-2026 - www.financetom.com All Rights Reserved